恒瑞医药9月11日斥资1592.66万元回购23.5万股A股

Core Viewpoint - Heng Rui Medicine (600276)(01276) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Category Company Actions - The company plans to repurchase 235,000 A-shares at a total cost of 15.9266 million RMB [1] - The buyback price per share ranges from 67.2 to 68.41 RMB [1] Financial Implications - The total expenditure for the buyback represents a strategic investment in the company's own shares, potentially enhancing shareholder value [1]